<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr7-1076029618792302">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oldenburg</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Bevans</surname>
    <given-names>CG</given-names>
   </name>
   <name>
    <surname>Fregin</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Geisen</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Müller-Reible</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Watzka</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles</article-title>. 
  <source>Thromb Haemost</source>. 
  <year>2007</year>;
  <volume>98</volume>(
  <issue>3</issue>):
  <fpage>570</fpage>–
  <lpage>578</lpage>.
  <pub-id pub-id-type="pmid">17849045</pub-id>
 </mixed-citation>
</ref>
